Pricop L, Rabinowich H, Morel P A, Sulica A, Whiteside T L, Herberman R B
University Carol Davilla School of Medicine, Bucharest, Romania.
J Immunol. 1993 Sep 15;151(6):3018-29.
After treatment with human normal IgM, 78 +/- 8% of purified CD3-CD56+ resting human NK cells and 93 +/- 6% of IL-2-activated NK cells selected by adherence to plastic reacted with FITC-goat anti-human IgM. Binding of IgM to the FcR for IgM (Fc mu R) on human NK cells was not species specific because mouse myeloma IgM also bound to these cells. The percentage of CD56+ cells binding IgM after incubation with anti-CD16 mAb was similar to that of cells incubated with medium alone (95 +/- 1% vs 93 +/- 4%). Binding of anti-CD16 mAb to Fc gamma RIII on NK cells was unaffected by pretreatment with IgM (65 +/- 12% vs 69 +/- 4%). The CD7 molecule has been reported to be the Fc mu R on the surface of T cells. Two-color flow cytometry showed that 94 +/- 3% of CD3-CD56+ resting NK cells and 71 +/- 16% of activated NK cells were CD7+. Preincubation of NK cells with three anti-CD7 mAb (Leu-9, 8H8-1, and LAU-A1) failed to block the binding of IgM to the Fc mu R. Modulation of the CD7 molecule off the cell surface (CD7+ = 1.5% +/- 0.3) did not reduce IgM binding, thus excluding the possibility that IgM anti-CD7 might bind to different epitopes of the same molecule. These data indicate that the Fc mu R is a specific Ig-binding structure, distinct from the Fc gamma RIII (CD16) or CD7. The Fc mu R on NK cells functions as a signal-transducing molecule because the addition of 0.2 mg/ml IgM to R-NK cells caused a rapid increase in [Ca2+]i (delta = 40 nM). One of the early events that followed signaling through the Fc mu R was the down-modulation of IFN-gamma gene expression and IFN gamma production in NK cells. The presence of IgM during culture of NK cells consistently decreased the expression of HLA-DR (16% vs 40% in control). Thus, the Fc mu R, a constitutively-expressed receptor on human NK cells, seems to be an important functional molecule, which delivers negative regulatory signals to NK cells.
用人类正常IgM处理后,78±8%的纯化CD3 - CD56 +静止人类自然杀伤(NK)细胞和93±6%通过贴壁选择的经白细胞介素-2激活的NK细胞与异硫氰酸荧光素(FITC)标记的山羊抗人IgM发生反应。IgM与人NK细胞上IgM的Fc受体(FcμR)的结合不具有种属特异性,因为小鼠骨髓瘤IgM也能与这些细胞结合。用抗CD16单克隆抗体孵育后结合IgM的CD56 +细胞百分比与仅用培养基孵育的细胞百分比相似(95±1%对93±4%)。抗CD16单克隆抗体与NK细胞上FcγRIII的结合不受IgM预处理的影响(65±12%对69±4%)。据报道,CD7分子是T细胞表面的FcμR。双色流式细胞术显示,94±3%的CD3 - CD56 +静止NK细胞和71±16%的活化NK细胞为CD7 +。用三种抗CD7单克隆抗体(Leu - 9、8H8 - 1和LAU - A1)对NK细胞进行预孵育未能阻断IgM与FcμR的结合。CD7分子从细胞表面下调(CD7 + = 1.5%±0.3)并未降低IgM结合,因此排除了抗CD7 IgM可能与同一分子的不同表位结合的可能性。这些数据表明,FcμR是一种特异性的Ig结合结构,与FcγRIII(CD16)或CD7不同。NK细胞上的FcμR作为一种信号转导分子发挥作用,因为向R - NK细胞中添加0.2mg/ml IgM会导致细胞内钙离子浓度([Ca2 +]i)迅速升高(变化量 = 40nM)。通过FcμR信号传导后早期发生的事件之一是NK细胞中γ干扰素(IFN - γ)基因表达和IFN - γ产生的下调。在NK细胞培养过程中IgM的存在持续降低人类白细胞抗原DR(HLA - DR)的表达(16%对对照组的40%)。因此,FcμR作为人类NK细胞上组成性表达的受体,似乎是一个重要的功能分子,它向NK细胞传递负调节信号。